These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 9550388)

  • 1. Single amino acid mutations in the murine MHC class II A beta cytoplasmic domain abrogate antigen presentation.
    Laufer TM; Smiley ST; Ranger A; Clements VK; Ostrand-Rosenberg S; Glimcher LH
    J Immunol; 1997 Dec; 159(12):5914-20. PubMed ID: 9550388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The extracellular domains of MHC class II molecules determine their processing requirements for antigen presentation.
    Kjer-Nielsen L; Perera JD; Boyd LF; Margulies DH; McCluskey J
    J Immunol; 1990 Apr; 144(8):2915-24. PubMed ID: 1969876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional effects of N-linked oligosaccharides located on the external domain of murine class II molecules.
    Wei BY; Buerstedde JM; Bell M; Chase C; Nilson A; Browne A; Pease L; McKean DJ
    J Immunol; 1991 Apr; 146(7):2358-66. PubMed ID: 1706396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rejection of mouse sarcoma cells after transfection of MHC class II genes.
    Ostrand-Rosenberg S; Thakur A; Clements V
    J Immunol; 1990 May; 144(10):4068-71. PubMed ID: 2332639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rejection of K1735 murine melanoma in syngeneic hosts requires expression of MHC class I antigens and either class II antigens or IL-2.
    Chen PW; Ananthaswamy HN
    J Immunol; 1993 Jul; 151(1):244-55. PubMed ID: 8326126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen presentation abrogated in cells expressing truncated Ia molecules.
    Nabavi N; Ghogawala Z; Myer A; Griffith IJ; Wade WF; Chen ZZ; McKean DJ; Glimcher LH
    J Immunol; 1989 Mar; 142(5):1444-7. PubMed ID: 2918224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Length and sequence requirements of the cytoplasmic domain of the A beta molecule for class II-mediated B cell signaling.
    Harton JA; Bishop GA
    J Immunol; 1993 Nov; 151(10):5282-9. PubMed ID: 8228224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. I-Ak polymorphisms define a functionally dominant region for the presentation of hen egg lysozyme peptides.
    Rosloniec EF; Vitez LJ; Beck BN; Buerstedde JM; McKean DJ; Landais D; Benoist C; Mathis D; Freed JH
    J Immunol; 1989 Jul; 143(1):50-8. PubMed ID: 2786533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abrogation of tumorigenicity by MHC class II antigen expression requires the cytoplasmic domain of the class II molecule.
    Ostrand-Rosenberg S; Roby CA; Clements VK
    J Immunol; 1991 Oct; 147(7):2419-22. PubMed ID: 1918972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presentation of antigens internalized through the B cell receptor requires newly synthesized MHC class II molecules.
    Forquet F; Barois N; Machy P; Trucy J; Zimmermann VS; Leserman L; Davoust J
    J Immunol; 1999 Mar; 162(6):3408-16. PubMed ID: 10092796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Class II-restricted presentation of a hen egg lysozyme determinant derived from endogenous antigen sequestered in the cytoplasm or endoplasmic reticulum of the antigen presenting cells.
    Brooks AG; McCluskey J
    J Immunol; 1993 May; 150(9):3690-7. PubMed ID: 8473726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of dominant negative effects of amino acid side chain substitution in peptide-MHC molecule interactions and T cell recognition.
    Boehncke WH; Takeshita T; Pendleton CD; Houghten RA; Sadegh-Nasseri S; Racioppi L; Berzofsky JA; Germain RN
    J Immunol; 1993 Jan; 150(2):331-41. PubMed ID: 8093457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rejection of MHC class II-transfected tumor cells requires induction of tumor-encoded B7-1 and/or B7-2 costimulatory molecules.
    Baskar S; Clements VK; Glimcher LH; Nabavi N; Ostrand-Rosenberg S
    J Immunol; 1996 May; 156(10):3821-7. PubMed ID: 8621919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polarized transport of MHC class II molecules in Madin-Darby canine kidney cells is directed by a leucine-based signal in the cytoplasmic tail of the beta-chain.
    Simonsen A; Pedersen KW; Nordeng TW; von der Lippe A; Stang E; Long EO; Bakke O
    J Immunol; 1999 Sep; 163(5):2540-8. PubMed ID: 10452991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arsonate-specific murine T cell clones. V. Antigen presentation by L cells transfected with normal and mutant class II genes.
    Norton FL; Davis CB; Jones PP; Goodman JW
    J Immunol; 1989 Jul; 143(2):446-51. PubMed ID: 2472438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphism in the beta chain of IAq versus IAp influences presentation of protein but not peptide antigens.
    Lambert LE; Berling JS; Thompson SD; Harton JA; Bishop GA; Choi E
    Cell Immunol; 1995 Oct; 165(2):202-10. PubMed ID: 7553884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replacement of N-glycosylation sites on the MHC class II E alpha chain. Effect on thymic selection and peripheral T cell activation.
    Ishikawa S; Kowal C; Cole B; Thomson C; Diamond B
    J Immunol; 1995 May; 154(10):5023-9. PubMed ID: 7730609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A site for CD4 binding in the beta 1 domain of the MHC class II protein HLA-DR1.
    Brogdon J; Eckels DD; Davies C; White S; Doyle C
    J Immunol; 1998 Nov; 161(10):5472-80. PubMed ID: 9820523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of the allele specific Ag-binding site on murine class II MHC].
    Kajino K
    Hokkaido Igaku Zasshi; 1996 Mar; 71(2):187-203. PubMed ID: 8641675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell surface expression of hybrid murine/human MHC class II beta alpha dimers. Key influence of residues in the amino-terminal portion of the beta 1 domain.
    Lechler RI; Sant AJ; Braunstein NS; Sekaly R; Long E; Germain RN
    J Immunol; 1990 Jan; 144(1):329-33. PubMed ID: 2404065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.